Thailand COVID-19 vaccine research programs

KinGen Biotech was appointed as one of the key manufacturers to take part in Thailand’s COVID-19 R&D program driven by the National Vaccine Institute, Ministry of Public Health of Thailand. The program foresees scale-up of local R&D vaccine candidates ranging from pDNA, recombinant proteins, viral vectors to plant-based proteins. KinGen Biotech is playing a vital role to provide GMP-grade bulk materials to be used in various stages of the vaccine development activities.